Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Docetaxel nanopolymer - Pfizer

Next Previous
Search
Drug Profile

Docetaxel nanopolymer - Pfizer

Alternative Names: BIND-014

Latest Information Update: 18 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Johns Hopkins University; Yale University
  • Developer BIND Therapeutics; Pfizer
  • Class Antineoplastics; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Non-small cell lung cancer

Highest Development Phases

  • Discontinued Cervical cancer; Cholangiocarcinoma; Head and neck cancer; Non-small cell lung cancer; Prostate cancer; Solid tumours; Urogenital cancer

Most Recent Events

  • 08 Sep 2021 Discontinued - Phase-I for Solid tumours (Late-stage disease) in USA (IV)
  • 08 Sep 2021 Discontinued - Phase-II for Cervical cancer (Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA, Russia (IV)
  • 08 Sep 2021 Discontinued - Phase-II for Cholangiocarcinoma (Late-stage disease, Metastatic disease, Second-line therapy or greater) in USA, Russia (IV)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top